Literature DB >> 7552066

Rheumatoid factors, B cells and immunoglobulin genes.

R Jefferis1.   

Abstract

The paradigm of self, non-self discrimination in the immune system is under review as autoreactive B or T cells are increasingly delineated within normal individuals. The products of autoreactive B cells are, mostly, polyspecific IgM antibodies of low affinity. These 'natural' antibodies include rheumatoid factors (RF) encoded by unmutated germline immunoglobulin genes. In rheumatoid arthritis (RA) the RF may be of the IgM, IgG or IgA isotype, show evidence of somatic mutation and have increased affinity; consistent with maturation of an antigen driven immune response. This response could be initiated or driven by an auto-immunogenic form of IgG or an exogenous cross-reactive antigen. Changes in galactosylation of IgG have been reported to be a valuable diagnostic and prognostic indicator in RA. Speculation that these changes may precipitate some of the disease processes is critically reviewed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7552066     DOI: 10.1093/oxfordjournals.bmb.a072963

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  4 in total

Review 1.  Do self-perpetuating B lymphocytes drive human autoimmune disease?

Authors:  J C Edwards; G Cambridge; V M Abrahams
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

2.  The co-expression of activating and inhibitory leukocyte immunoglobulin-like receptors in rheumatoid synovium.

Authors:  Nicodemus Tedla; Kathryn Gibson; H Patrick McNeil; David Cosman; Luis Borges; Jonathan P Arm
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

3.  The gut-joint axis: cross reactive food antibodies in rheumatoid arthritis.

Authors:  M Hvatum; L Kanerud; R Hällgren; P Brandtzaeg
Journal:  Gut       Date:  2006-02-16       Impact factor: 23.059

4.  Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations.

Authors:  F Mackay; S A Woodcock; P Lawton; C Ambrose; M Baetscher; P Schneider; J Tschopp; J L Browning
Journal:  J Exp Med       Date:  1999-12-06       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.